Evogene Ltd. (TLV:EVGN)
264.20
+7.90 (3.08%)
At close: Mar 13, 2026
Evogene Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 12.96 | 15.3 | 20.77 | 28.98 | 32.33 |
Short-Term Investments | - | 0.01 | 10.29 | - | 3 |
Trading Asset Securities | - | - | - | 6.38 | 18.54 |
Cash & Short-Term Investments | 12.96 | 15.31 | 31.06 | 35.36 | 53.87 |
Cash Growth | -15.38% | -50.71% | -12.14% | -34.37% | 11.69% |
Accounts Receivable | 0.32 | 1.09 | 0.36 | 0.35 | 0.28 |
Other Receivables | 1.57 | 0.34 | 0.31 | 0.35 | 0.89 |
Receivables | 1.88 | 1.43 | 0.67 | 0.7 | 1.17 |
Inventory | 0.21 | 1.82 | 0.08 | 0.57 | 0.09 |
Prepaid Expenses | - | 0.36 | 1.04 | 1.1 | 1.69 |
Restricted Cash | 0.03 | - | - | 0.03 | 0.08 |
Other Current Assets | 0.55 | 2.66 | 1.62 | - | - |
Total Current Assets | 15.63 | 21.59 | 34.47 | 37.75 | 56.89 |
Property, Plant & Equipment | 2.64 | 4.25 | 3.44 | 4.07 | 4.18 |
Long-Term Investments | 0.04 | 0.08 | - | - | - |
Other Intangible Assets | - | 12.2 | 13.17 | 14.14 | 15.21 |
Long-Term Deferred Tax Assets | - | - | - | 0.09 | - |
Long-Term Deferred Charges | 1.17 | 1.74 | - | - | - |
Other Long-Term Assets | 0.57 | 0.01 | 0.03 | 0.07 | 0.03 |
Total Assets | 20.05 | 39.86 | 51.1 | 56.13 | 76.3 |
Accounts Payable | 0.64 | 1.23 | 1.79 | 1.04 | 1.46 |
Accrued Expenses | 0.86 | 2.19 | 3.09 | 2.37 | 3.15 |
Current Portion of Leases | 0.72 | 0.59 | 0.85 | 0.88 | 0.97 |
Current Unearned Revenue | 0.07 | 0.68 | 0.75 | 0.1 | 0.26 |
Other Current Liabilities | 1.16 | 14 | 0.46 | 1.24 | 1.03 |
Total Current Liabilities | 3.44 | 18.7 | 6.94 | 5.63 | 6.88 |
Long-Term Leases | 1.48 | 1.91 | 0.29 | 0.93 | 1.7 |
Long-Term Unearned Revenue | 3.15 | 4.42 | 4.82 | 4.67 | 4.31 |
Other Long-Term Liabilities | - | - | 10.37 | 10.11 | - |
Total Liabilities | 8.07 | 25.03 | 22.42 | 21.34 | 12.88 |
Common Stock | 0.49 | 0.36 | 0.29 | 0.24 | 0.23 |
Additional Paid-In Capital | 281.99 | 272.26 | 269.35 | 261.4 | 260.49 |
Retained Earnings | -282.56 | -274.07 | -257.59 | -233.71 | -207.07 |
Total Common Equity | -0.08 | -1.45 | 12.05 | 27.93 | 53.65 |
Minority Interest | 12.06 | 16.29 | 16.63 | 6.86 | 9.77 |
Shareholders' Equity | 11.98 | 14.84 | 28.69 | 34.79 | 63.42 |
Total Liabilities & Equity | 20.05 | 39.86 | 51.1 | 56.13 | 76.3 |
Total Debt | 2.2 | 2.5 | 1.14 | 1.82 | 2.67 |
Net Cash (Debt) | 10.76 | 12.81 | 29.93 | 33.54 | 51.2 |
Net Cash Growth | -16.01% | -57.20% | -10.78% | -34.49% | 11.81% |
Net Cash Per Share | 1.37 | 2.25 | 6.52 | 8.10 | 12.66 |
Filing Date Shares Outstanding | 8.72 | 6.51 | 5.06 | 4.16 | 4.12 |
Total Common Shares Outstanding | 8.72 | 6.51 | 5.06 | 4.13 | 4.12 |
Working Capital | 12.19 | 2.89 | 27.53 | 32.13 | 50.01 |
Book Value Per Share | -0.01 | -0.22 | 2.38 | 6.77 | 13.03 |
Tangible Book Value | -0.08 | -13.65 | -1.12 | 13.79 | 38.45 |
Tangible Book Value Per Share | -0.01 | -2.09 | -0.22 | 3.34 | 9.34 |
Machinery | - | 8.12 | 7.54 | 6.95 | 6.12 |
Leasehold Improvements | - | 13.1 | 14.03 | 13.87 | 13.51 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.